Abstract: Cupressus sempervirens L. (Cupressaceae) is a species of cypress native to the eastern Mediterranean region. The ethanol extract of the powdered cones (fruits) of this plant, collected from Oxford, Mississippi during the fall of 2010, exhibited potent antimicrobial and antiparasitic activities. Bioassay-guided fractionation using a centrifugal preparative thin-layer chromatography yielded two potent antileishmanial and antimicrobial diterpenes, 6-deoxytaxodione (11-hydroxy-7, 9(11), 13-abietatrien-12-one) (1) and taxodione (2), together with ferruginol (3) and sugiol (4). Compounds 1 and 2 displayed potent antileishmanial activity with half-maximal inhibitory concentration (IC 50 ) values of 0.077 µg/mL and 0.025 µg/mL, respectively, against Leishmania donovani promastigotes, compared to those of the standard antileishmanial drugs, pentamidine (IC 50 1.62 µg/mL) and amphotericin B (IC 50 0.11 µg/mL). Compounds 1-3 were also evaluated against L. donovani amastigotes in THP1 macrophage cultures. In addition, both 1 and 2 showed potent antibacterial activities (IC 50 0.80 and 0.85 µg/mL) against methicillin-resistant Staphylococcus aureus. Compounds 1 and 2 had previously been isolated from Clerodendrum eriophyllum, where 2 showed potent cytotoxic activity. However, this is the first report of antimicrobial and antileishmanial activities of compound 1.
Introduction
Cupressus sempervirens L. (Cupressaceae), the Mediterranean Cypress (also known as Italian, Tuscan, or Graveyard Cypress, or Pencil Pine) is a species of cypress native to the eastern Mediterranean region, northeast Libya, southeast Greece (Crete, Rhodes), southern Turkey, Cyprus, northern Egypt, western Syria, Lebanon, Israel, Malta, Italy, western Jordan, and also a large indigenous population in Iran. This plant is naturalized in the USA and has been widely cultivated as an ornamental tree. 1 C. sempervirens has been traditionally used for the treatment of cold, flu, sore throat and rheumatism. 2 The branches of this plant are used as antiseptics and antispasmodics. 3 Phytopreparation obtained from the cores and young branches of C. sempervirens was reported to have antiseptic, aromatherapeutic, astringent, balsamic and antiinflammatory activities. Abietane diterpenoids have been isolated from the fruits of C. sempervirens and were evaluated for their inhibitory activity against glycogen phosphorylase and glucose-6-phosphatase enzymes. 4 Leishmaniasis is an important tropical vector-borne disease that causes considerable mortality throughout the world. Visceral leishmaniasis, caused by Leishmania donovani, is a severe form in which the parasites have migrated to the vital organs.
Approximately 350 million people live in the areas where Leishmaniasis can be transmitted. It affects as many as 12 million people worldwide, with 1.5-2 million new cases each year. 5 However, the current treatment regimens for this parasite are limited and are not ideal, as they are often associated with severe side effects and resistant strains of the parasite have developed. The second-line drugs, amphotericin B and pentamidine, show high toxicity at their effective therapeutic doses. Also, during the treatment for visceral or mucocutaneous leishmaniasis, parasites become resistant to the current treatment therapies of antimony or amphotericin B in many parts of the world, 6, 7 hence the search for new, safe and easy-to-administer drugs remains a top priority.
In our search for antiparasitic and antimicrobial compounds from natural resources, we found the ethanol extract of cones of C. sempervirens displayed significant activity against Leishmania donovani promastigotes, hence this plant was investigated further. In this paper we report the isolation of four known abietane diterpenoids, 6-deoxytaxodione (1), taxodione (2), ferruginol (3), and sugiol (4), according to the bioassay-guided fractionation using a centrifugal preparative thin-layer chromatography (CPTLC; Chromatotron ® ; Harrison Research, Palo Alto, CA), as well as their antileishmanial, antimalarial, and antimicrobial activities.
Materials and methods general procedure
Proton nuclear magnetic resonance imaging ( 1 H-NMR) spectra at 400 MHz and carbon-13 NMR ( 13 C-NMR) spectra at 100 MHz were recorded on a Varian Mercury 400 spectrometer (Varian Inc, Palo Alto, CA 
Drugs and chemicals
For column chromatography (CC), silica gel (32-63 mesh; Merck, Darmstadt, Germany) was used as stationary phases. Certified solvents (MeOH, hexane, EtOAc, etc; Fisher Chemical, Fairlawn, NJ) were used as mobile phases for CPTLC and CC. Samples were dissolved in CDCl 3 solution (Cambridge Isotope Laboratories, Andover, MA) for one-dimensional (1D) and 2D NMR using the residual solvent as the international standard. Ciprofloxacin (99.3% purity; ICN Biomedicals, Aurora, OH) for bacteria and amphotericin B (94.8% purity; ICN Biomedicals) for fungi were used as drug controls in antimicrobial assay. Pentamidine and amphotericin B (Sigma-Aldrich, St Louis, MO) were used as standard antileishmanial agents. Chloroquine and artemisinin (Sigma-Aldrich) were used as drug controls in the antimalarial assay.
Plant materials
A sample of the fruits (cones) of this plant was collected from Oxford, Mississippi during the fall of 2010 and identified by Dr Vijayasankar Raman, National Center of Natural Product Research (NCNPR), University of Mississippi.
Extraction and isolation
The dried, powdered cones (63 g) were extracted by percolation with 95% EtOH (1 L × seven times) and the combined extracts were concentrated to dryness using a rotary evaporator at 45°C. The dried exact was subjected to biological assay for antileishmanial, antimalarial, and antimicrobial activities at NCNPR and showed good activities. Therefore, the dried crude extract (9 g) was subjected to bioassay-guided fractionation using silica gel column (32-63 mesh, 270 g silica; Merck) with gradient elution of n-hexane-EtOAc (99:1-50:50). Fractions were collected in 100 mL aliquots and were combined to yield 27 fractions based on TLC analysis. Fraction 5 (84 mg), which showed good activities in biological assay, was further purified using CPTLC (Chromatotron ® , 1 mm silica rotor) with n-hexane-acetone (99.5:0.5) to afford 6-deoxytaxodione (1, 4.8 mg) from subfraction 21-26, taxodione (2, 6.7 mg) from sub-fraction 30-33, and ferruginol (3, 43.6 mg) from subfraction 37-45. On the other hand, sugiol (4, 49 mg) was crystallized from fraction 20 (208 mg).
Antileishmanial assay
The in vitro antileishmanial assay was done on a culture of L. donovani promastigotes by Alamar Blue assay, which is designed to measure quantitatively the proliferation of various human and animal cell lines, bacteria and fungi. 8 In a 96-well microplate the samples with appropriate dilution were added to the Leishmania promastigotes culture (2 × 10 6 cells/mL) to get the final concentrations of 80 µg/mL. was determined. Pentamidine and amphotericin B were used as standard antileishmanial agents. Half-maximal inhibitory concentration (IC 50 ) values for each compound were computed from the growth-inhibition curve.
In vitro macrophage amastigote assay
A recently developed promastigote rescue assay was used. 9 The THP1 cells (human acute monocytic leukemia cell line) were maintained in RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS). The cells were prepared prior to each assay and suspended in RPMI-1640 medium with 10% FBS at a cell density of 2.5 × 10 5 cells/mL. Phorbol 12-myristate 13-acetate (PMA) was added to the cell suspension to achieve final concentration of 25 ng/mL and cells were seeded onto a clear flat-bottom 96-well plate with 200 µL (5 × 10 4 cells) into each well. The plate was incubated in a 5% CO 2 incubator at 37°C for at least 12 hours for differentiation of the THP1 cells to adherent macrophages. After overnight incubation the medium from each well was discarded and adherent cells were gently washed at least twice with serum-free RPMI-1640 medium. The Leishmania donovani promastigotes culture was harvested at the stationary phase (metacyclic infective stage) and suspended into RPMI-1640 medium with 2% FBS at the density of 2.5 × 10 6 cells/mL. The 200 µL of promastigotes (5 × 10 5 cells/mL) culture was added to each well. The plate was further incubated in a 5% CO 2 incubator at 37°C for at least 24 hours to allow infection of macrophages with the Leishmania parasites. After 24 hours the nonadherent macrophages and unattached Leishmania promastigotes were washed off with serum free RPMI-1640 medium. The infected macrophages were further incubated at 37°C and 5% CO 2 
Antimalarial assay
The in vitro antiplasmodial activity was measured by a colorimetric assay that determines the parasitic lactate dehydrogenase (pLDH) activity. 10 The assay was performed in a 96-well microplate and included two Plasmodium falciparum clones (Sierra Leone D6 [chloroquine-sensitive] and Indochina W2 [chloroquine-resistant]; Walter Reed Army Institute of Research, Silver Spring, MD). For the assay, a suspension of red blood cells infected with P. falciparum (D6 or W2) strains (200 µL, with 2% parasitemia and 2% hematocrit in RPMI-1640 medium supplemented with 10% human serum and 60 µg/mL amikacin) was added to the wells of a 96-well plate containing 10 µL of test samples at various concentrations. The plate was flushed with a gas mixture of 90% N 2 , 5% O 2 , and 5% CO 2 in a modular incubation chamber (4464 M; Billups-Rothenberg, San Diego, CA) and incubated at 37°C for 72 hours. Plasmodial LDH activity was determined by using Malstat reagent (Flow Inc, Portland, OR) as described earlier. 10 The IC 50 values were computed from the dose-response curves generated by plotting percent growth against test concentrations. Dimethyl sulfoxide (0.25%), artemisinin, and chloroquine were included in each assay as vehicle and drug controls, respectively. The selectivity indices (SI) were determined by measuring the cytotoxicity of samples toward mammalian cells (Vero; monkey kidney fibroblast). All experiments were carried out in duplicate. 
Antimicrobial assay

Results and discussion
A bioassay-guided fractionation, followed by repeated purification using centrifugal preparative TLC of the C NMR, together with 2D NMR spectral experiments. The NMR spectral data of compound 1-4 were in agreement with those reported previously for 11-hydroxy-7, 9 (11), 13-abietatrien-12-one, taxodione, ferruginol and sugiol, respectively. [13] [14] [15] [16] [17] Compound 1 was named as 6-deoxytaxodione (Figure 1) .
Compounds 1 and 2 displayed potent antileishmanial activity with IC 50 values of 0.077 µg/mL and 0.025 µg/mL, respectively, against L. donovani promastigotes. Compound 2 was found to be .64-and .4.4-fold more potent than those observed for the standard antileishmanial drugs, pentamidine (IC 50 1.62 µg/mL) and amphotericin B (IC 50 0.11 µg/mL), respectively, while compound 1 was .21-and .1.4-fold potent than these standards. Compounds 1-3 were also evaluated against L. donovani amastigotes in THP1 macrophage cultures and only 3 showed cytotoxicity towards transformed THP1 cells (Table 1) , which was equipotent to pentamidine. However, compound 1 demonstrated the best activity without any cytotoxicity against THP1 cells. The weak antimalarial activities of compounds 1 and 2 against P. falciparum D6 and W2 strains were attributed by low IC 50 values of 1.9-3.0 µg/mL, compared with standard drugs of chloroquine and artemisinin (Table 2) .
Among all the compounds, the antimicrobial activity was strongly displayed by compound 2 against C. albicans, C. glabrata, C. krusei, A. fumigatus, C. neoformans, S. aureus, MRSA, and Mycobacterium intracellulare. Compound 2 showed potent inhibition against C. glabrata and C. neoformans with IC 50 values , 0.8 µg/mL compared to the IC 50 values of 0.24 µg/mL and 0.36 µg/mL of standard drug amphotericin B, respectively. Compound 1 was generally weakly active compared to 2 against most of these organisms, except MRSA where the IC 50 value was found to be 0.85 µg/mL (Table 3 ).
All four compounds had previously been isolated from Clerodendrum eriophyllum (Fabaceae), a plant collected from Kenya, where compound 2 showed potent cytotoxic activity. 17 However, this appears to be the first report of compounds 1 and 2 from the C. sempervirens, and also this is the first report of antimicrobial and antileishmanial activity of compound 1.
